EMA CHMP issues positive opinion recommending EU approval of Eli Lilly's Foundayo for type 2 diabetes and weight management

Eli Lilly received a positive opinion from the EMA's CHMP recommending marketing authorization for Foundayo for the treatment of type 2 diabetes mellitus and for weight management.

Detected & updated continuously · Source: Nebula